emrupdate.com
emrupdate.com
Unbiased independant EMR discussions.

Gleeman’s Daily News—03/31

Loading

 

Ask the Consultant: a free consultation program here  at Emrupdate.com

Michael Uretz, Executive Director
The EHR Group
700 NW Gilman Blvd. Suite E293
Issaquah, WA 98027
Tel: +1 (425) 434-7102

Our first Ask the Consultant subject is about Asking the Right Technical Questions.

This is not at all designed to delve into the bits and bytes of technology, but to give you the terminology and grasp of issues that you need to know in these discussions. You can still post your technical questions in the IT and Geeky forum, where many wise and eminent Doctor Technology experts will probably disagree with each other, but still provide some answers for you!

So, this is our first Ask the Consultant Session with our guest consultant Michael Uretz. Thanks to Mike for being our first Ask the Consultant.

Please leave any specific or general questions in reply to the post or send an email to Mike, Robert Gleeman or myself. We’ll post a link to Ask the Consultant response here when submitted.

5-way “poly-pill” may someday reduce heart attacks and strokes by 50%

Polypill Could Dramatically Reduce Heart Disease Risk One Day

“Before this study, there were no data about whether it was even possible to put five active ingredients into a single pill, in terms of feasibility, the biovailability of different agents and possible interactions. We found that it works,” said Salim Yusuf of the Population Health Research Institute at McMaster University, who presented the data at the cardiology meeting.

Based on the study findings, the polypill could reduce heart disease by 60 percent and stroke by 50 percent.

This gives me the feeling that I am on the right meds and ahead of the game, a strange feeling indeed.

Glaxo resubmits Cervarix, the competition to Gardasil, for approval in the U.S.

Glaxo Resubmits Cervarix To U.S. Regulators

Author
Reuters File photo

Cervarix, which is already approved in more than 90 countries around the world, including major European markets, competes with Merck & Co Inc's Gardasil in protecting against the sexually transmitted cancer-causing human papillomavirus.

Glaxo is relying on Cervarix to drive future growth in its vaccines unit, which has been identified by Chief Executive Andrew Witty as a priority area and a target for bolt-on acquisitions.

In this story, the choice of photos may be misleading, in that the drug in question is most likely a liquid injection, not a pill.

Pistachios from California tied to latest salmonella recall

PHOTO Officials are investigating a central California plant that processed pistachios tied to nationwide recalls of trail mix and bagged nuts because of possible salmonella contamination.

Officials are investigating a central California plant that processed pistachios tied to nationwide recalls of trail mix and bagged nuts because of possible salmonella contamination. (ABC News Photo Illustration)

Still reeling from the national salmonella outbreak in peanuts, the Food and Drug Administration said central California-based Setton Pistachio of Terra Bella Inc., the nation's second-largest pistachio processor, was voluntarily recalling a portion of the roasted nuts it has been shipping since last fall. A Setton spokeswoman said that amounts to more than 2 million pounds of nuts.

Strange that nuts, all of a sudden, are difficult to prepare safely? I always thought nuts were a “pure” food, hard to spoil.

Panel says all teens should be screened for depression

All teens should be screened for depression, even if they don’t necessarily show signs of the blues, an influential government panel is recommending, noting that the majority of afflicted teens aren’t diagnosed or treated even though there are effective therapies.

Depression is a life-threatening illness, and it can lead to so many other problems as well. By all means, we need these tests.

Bristol-Myers diabetes drug appears safe for the heart

FDA: Bristol-Myers diabetes drug appears safe

WASHINGTON (AP) — A potential blockbuster diabetes medication from Bristol-Myers Squibb appears free from heart-related side effects that have plagued similar treatments, federal health officials said Monday.

More good news for type 2 diabetics, this new drug seems to beat the heart-risk problems of competing drugs.

Risk of sudden death associated with nine gene combinations

Heart scan (Source: ONE News)

Researchers have found nine new gene variations that can make a person vulnerable to sudden cardiac death and confirmed the role of another, international researchers say.

"Almost half were surprising new genes that no one would have guessed as being involved in cardiac biology," said Dan Arking of Johns Hopkins University School of Medicine, whose team was one of many working on the study in the journal Nature Genetics.

It is becoming so amazing what science can read from the genes, perhaps the future of all diagnostics.


Posted Mar 31 2009, 09:56 AM by Robert Gleeman
 
©2008 emrupdate.com. All rights reserved. | Acceptable Use Policy | Proud to be supported by the following EMR Vendor Sponsors:

eClinicalWorks | DescriptMED |  EMR Experts |  Medical Office Online | NextGen | SynapseDirect | TSI Healthcare